ABCL – AbCellera Biologics Inc.
[iframe https://s.tradingview.com/embed-widget/symbol-info/?locale=in&symbol=ABCL
#%7B%22symbol%22%3A%22A%22%2C%22width%22%3A%22100%25%22%2C%22colorTheme%22%3A%22light%22%2C%22isTransparent%22%3Atrue%2C%22height%22%3A203%2C%22utm_source%22%3A%22themarketstracker.com%22%2C%22utm_medium%22%3A%22widget_new%22%2C%22utm_campaign%22%3A%22symbol-info%22%7D 900 250 ]
[iframe https://api.stockdio.com/visualization/financial/charts/v1/PricesChange?app-key=F086EEE750E14D8D8A456DB88B2D6D8C&symbol=ABCL
&conditionalVolume=false&allowPeriodChange=false&tooltipsStyle=None&palette=Financial-Light&showBorderAndTitle=false 300 200 ]
Float Short %
21
Margin Of Safety %
Put/Call OI Ratio
0.14
EPS Next Q Diff
EPS Last/This Y
-0.1
EPS This/Next Y
-0.04
Price
4.64
Target Price
9.83
Analyst Recom
1.25
Performance Q
-16.85
Relative Volume
1.61
Beta
0.79
Ticker: ABCL
of 1
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-12-26 | ABCL | 3.59 | 0.10 | 0.33 | 99852 |
| 2025-12-29 | ABCL | 3.46 | 0.10 | 0.29 | 99943 |
| 2025-12-30 | ABCL | 3.44 | 0.10 | 0.41 | 100129 |
| 2025-12-31 | ABCL | 3.41 | 0.10 | 0.26 | 100086 |
| 2026-01-02 | ABCL | 3.41 | 0.10 | 0.07 | 100081 |
| 2026-01-05 | ABCL | 3.42 | 0.10 | 0.48 | 101688 |
| 2026-01-06 | ABCL | 3.9 | 0.10 | 0.16 | 101683 |
| 2026-01-07 | ABCL | 4.13 | 0.11 | 0.27 | 102850 |
| 2026-01-08 | ABCL | 4.11 | 0.11 | 0.17 | 104186 |
| 2026-01-09 | ABCL | 4.38 | 0.11 | 0.13 | 105425 |
| 2026-01-12 | ABCL | 4.53 | 0.11 | 0.09 | 106472 |
| 2026-01-13 | ABCL | 4.28 | 0.11 | 0.66 | 106810 |
| 2026-01-14 | ABCL | 4.29 | 0.12 | 0.06 | 107369 |
| 2026-01-15 | ABCL | 4.2 | 0.12 | 0.24 | 107182 |
| 2026-01-16 | ABCL | 4.11 | 0.12 | 0.08 | 108785 |
| 2026-01-20 | ABCL | 4.16 | 0.13 | 0.65 | 65785 |
| 2026-01-21 | ABCL | 4.3 | 0.14 | 0.26 | 67044 |
| 2026-01-22 | ABCL | 4.64 | 0.14 | 0.18 | 67320 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-12-26 | ABCL | 3.58 | -58.3 | - | -0.65 |
| 2025-12-29 | ABCL | 3.47 | -58.3 | - | -0.65 |
| 2025-12-30 | ABCL | 3.45 | -58.3 | - | -0.65 |
| 2025-12-31 | ABCL | 3.41 | -58.3 | - | -0.65 |
| 2026-01-02 | ABCL | 3.41 | -58.3 | - | -0.65 |
| 2026-01-05 | ABCL | 3.43 | -58.3 | - | -0.65 |
| 2026-01-06 | ABCL | 3.90 | -58.3 | - | -0.65 |
| 2026-01-07 | ABCL | 4.12 | -58.3 | - | -0.65 |
| 2026-01-08 | ABCL | 4.12 | -58.3 | - | -0.65 |
| 2026-01-09 | ABCL | 4.38 | -58.3 | - | -0.65 |
| 2026-01-12 | ABCL | 4.53 | -58.3 | - | -0.65 |
| 2026-01-13 | ABCL | 4.28 | -58.3 | - | -0.65 |
| 2026-01-14 | ABCL | 4.30 | -58.3 | - | -0.65 |
| 2026-01-15 | ABCL | 4.20 | -58.3 | - | -0.65 |
| 2026-01-16 | ABCL | 4.11 | -58.3 | - | -0.65 |
| 2026-01-20 | ABCL | 4.16 | -58.3 | - | -0.65 |
| 2026-01-21 | ABCL | 4.30 | -58.3 | - | -0.65 |
| 2026-01-22 | ABCL | 4.64 | -58.3 | - | -0.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-12-26 | ABCL | 0.00 | -1.78 | 21.97 |
| 2025-12-29 | ABCL | 0.00 | -1.76 | 21.97 |
| 2025-12-30 | ABCL | 0.00 | -1.76 | 21.97 |
| 2025-12-31 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-02 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-05 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-06 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-07 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-08 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-09 | ABCL | 0.00 | -1.76 | 21.97 |
| 2026-01-12 | ABCL | 0.00 | -1.77 | 21.97 |
| 2026-01-13 | ABCL | 0.00 | -1.77 | 21.00 |
| 2026-01-14 | ABCL | 0.00 | -1.77 | 21.00 |
| 2026-01-15 | ABCL | 0.00 | -1.77 | 21.00 |
| 2026-01-16 | ABCL | 0.00 | -1.77 | 21.00 |
| 2026-01-20 | ABCL | 0.00 | -1.80 | 21.00 |
| 2026-01-21 | ABCL | 0.00 | -1.80 | 21.00 |
| 2026-01-22 | ABCL | 0.00 | -1.80 | 21.00 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
[iframe https://widget.finnhub.io/widgets/historical-eps?symbol=ABCL
589 360 ]
Last Quarter Act. EPS
-0.19
Avg. EPS Est. Current Quarter
-0.19
Avg. EPS Est. Next Quarter
-0.18
Insider Transactions
Institutional Transactions
-1.8
Beta
0.79
Average Sales Estimate Current Quarter
6
Average Sales Estimate Next Quarter
14
Fair Value
Quality Score
21
Growth Score
35
Sentiment Score
67
Actual DrawDown %
91.6
Max Drawdown 5-Year %
-96.4
Target Price
9.83
P/E
Forward P/E
PEG
P/S
39.32
P/B
1.44
P/Free Cash Flow
EPS
-0.58
Average EPS Est. Cur. Y
-0.65
EPS Next Y. (Est.)
-0.69
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-486.01
Relative Volume
1.61
Return on Equity vs Sector %
-45.1
Return on Equity vs Industry %
-29.1
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.05
EBIT Estimation
[iframe https://widget.finnhub.io/widgets/recommendation?symbol=ABCL
589 450 ]
[iframe https://widget.finnhub.io/widgets/eps-estimate?symbol=ABCL
589 450 ]
AbCellera Biologics Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 596
AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its product pipeline includes ABCL635, an antibody-drug candidate, which is in preclinical trial to treat metabolic and endocrine conditions; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in preclinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada.
stock quote shares ABCL – AbCellera Biologics Inc. Stock Price stock today
news today ABCL – AbCellera Biologics Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ABCL – AbCellera Biologics Inc. yahoo finance google finance
stock history ABCL – AbCellera Biologics Inc. invest stock market
stock prices ABCL
premarket after hours
ticker ABCL
fair value insiders trading